Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2025-12-25 @ 3:10 AM
NCT ID:
NCT07246005
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of LV thrombus less than 12 months ago
* On Apixaban at the time of randomisation
* Completed at least 3 months of anticoagulation treatment for LV thrombus
* Persistent laminar/ mural thrombus or persistent LV dysfunction
Exclusion Criteria:
* Any clinical condition requiring long term anticoagulation treatment as per investigator's judgement.
* SSE since LV thrombus diagnosis
* Contraindication to continuing anticoagulation therapy
* Non-ischaemic Cardiomyopathy
* Age less than 18 years
* Unable to consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07246005
Study Brief:
Protocol Section:
NCT07246005